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Background 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Resolution of inflammation is an active process mediated by lipid mediators, and 
return to homeostasis is maintained by a balance between pro-inflammatory and pro-
resolving pathways 
Omega-3 PUFAs have anti-inflammatory and pro-resolving activity in pre-clinical 
disease models (e.g. peritonitis, colitis, asthma) 
Chronic inflammation is a key factor in the pathogenesis of numerous diseases (e.g. 
COPD, RA, IBD) 
Addition of DHA in combination with another ω-3 PUFAs results in 
additive/synergistic attenuation of nitric oxide (nitrite) production 
in LPS-stimulated RAW264.7 macrophages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nitric oxide (NO) production was indirectly assessed as previously described.  
RAW264.7 macrophages were seeded at a density of 200,000 cells/ml and pre-treated 
with the indicated concentrations (in μM) and combinations of ω-3 PUFAs ~18 hours 
prior to a 24 hour LPS (1 μg/ml) stimulation.  Data is represented as mean + SEM for 
n=3.  *p<0.01 versus LPS-treated cultures by one-way ANOVA; #p<0.001 versus LPS-
treated cultures by one-way ANOVA. (nd = not detected by sensitivity of assay.) 
 
Exposure to ω-3 PUFAs attenuates iNOS and COX-2 expression in 
LPS-stimulated RAW264.7 macrophages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Western blot:  RAW264.7 macrophages were seeded at a density of 200,000 cells/ml 
and pre-treated with ω-3 PUFAs ~18 hours prior to a 24 hour LPS (1 μg/ml) stimulation. 
All ω-3 PUFAs were tested at a dose of 100 μM.  Non-treated (NT) cultures were treated 
with the same final concentration of ethanol as vehicle.  Cell lysates were collected and 
subjected to western blot analysis using an anti-iNOS, anti-COX-2, or anti-GAPDH 
antibody.  The antibody-specific bands were quantified by densitometry and were 
normalized to GAPDH.  Blot shown is a representative image from 3 independent 
experiments. 
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Abstract 
Objective:  Macrophages are important to study in the context of inflammation given 
that their physiological locality situates these cells to respond to the initial 
inflammatory insult.  Dietary supplementation with omega-3 polyunsaturated fatty 
acids (ω-3 PUFAs) have been shown to decrease levels of inflammatory mediators 
produced by macrophages, yet little is known with regard to their therapeutic 
mechanism of action(s). This study is set to determine if the introduction of ω-3 PUFAs 
promote inflammation-resolution as a result of modifying the functional phenotype 
and/or molecular pathway profile of activated macrophages during an inflammatory 
cascade. 
 
Methods:  As a model for macrophage immune cell function, RAW264.7 cells, a murine-
derived macrophage cell line, was exposed to inflammatory stimuli following pre-
treatment with n-3 PUFAs.  Cells were treated with different doses/combinations of 
alpha linolenic acid (ALA), docosahexaenoic acid (DHA), and eicosapentaenoic acid 
(EPA) prior to macrophage activation to assess the combinatory impact of dietary n-3-
PUFAs.  To model an inflammatory event, RAW264.7 were stimulated with bacterial 
lipopolysaccharide (LPS).  Cell culture supernatants and cell lysates were collected and 
analyzed for different biomarkers of inflammation. The tests performed included Griess 
reaction (to measure the production of nitrite) and western blots (to measure levels of 
inflammatory proteins).   
 
Results:  A decrease in the inflammatory markers cyclooxygenase-2 (COX-2) and 
inducible nitric oxide synthase (iNOS) were detected by western blot analyses with 
various concentrations and DHA and EPA, compared to control samples.  The most 
significant decreases in nitrite levels were observed in cultures treated alone or in 
combination with DHA. Current studies are underway to evaluate changes in the 
functional phenotype of macrophages (i.e. phagocytic ability, TNF-alpha expression) 
following ω-3 PUFA treatment and LPS activation.   
 
Clinical Implications:  Understanding the biological role of n-3 PUFAs in inflammation 
will advance the knowledge-base into the therapeutic role it can play in reducing 
inflammation and developing novel therapies to treat chronic inflammatory diseases.  
 
Exposure to ω-3 PUFAs attenuates the levels of nitric oxide 
(nitrite) production in LPS-stimulated RAW264.7 macrophages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nitrite Measurement:  Nitric oxide (NO) production was indirectly assessed by 
measuring nitrite (a primary metabolite of NO) levels in cultured media (colorimetric-
based Griess reaction). RAW264.7 macrophages were seeded at a density of 200,000 
cells/ml and pre-treated with ω-3 PUFAs ~18 hours prior to a 24 hour LPS (1 μg/ml) 
stimulation.  Data is represented as mean + SEM for n=3.  *p<0.01 versus LPS-treated 
cultures by one-way ANOVA 
  
 
Conclusions 
 
The action of ω-3 PUFAs drives the decrease in proinflammatory mediators: COX-2, 
iNOS, and nitric oxide (nitrite) 
DHA is shown to have additive/synergistic effects when combined with other ω-3 
PUFAs   
The polarization of macrophages during inflammatory responses to functionally 
distinct phenotypes may play a role in both inflammation and resolution of 
inflammation following treatment with ω-3 PUFAs.   
 
